Posts Tagged ‘booster’
Higher risk for COVID? CDC and FDA recommend updated, bivalent booster
Following FDA regulatory action, CDC has taken steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want the option of added protection from additional COVID-19 vaccine doses. CDC’s Advisory Committee on Immunization Practices (ACIP) met today to discuss these COVID-19 vaccine recommendation changes, and the associated implications and implementation. Although…
Read MoreNEW: Moderna announces new booster that is Omicron variant specific
Moderna announces new booster that is Omicron variant specific Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing mRNA-1273 (Spikevax) and a vaccine candidate targeting the Omicron variant of concern. A 50 µg booster dose of mRNA-1273.214 met…
Read MoreCDC, FDA , RI Health Dept: 4th vaccine (2nd booster) now for those over 50, others
In Rhode Island, getting the 4th shot was not yet available at most pharmacies, as their policy is waiting until the CDC issues their approval (following the FDA). Yesterday, that step happened and the RI Department of Health included information on their site. People should now be able to make their appointments at the various…
Read MoreModerna joins Pfizer in recommending 4th vaccine, but expands to all adults, 18+
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted a request to the U.S. Food and Drug Administration (FDA) for an amendment to the emergency use authorization (EUA) to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273) in adults 18 years of age and…
Read MoreExpanded use of Pfizer boosters for some children approved by FDA.
The 3-step process of to bring vaccinations to the American public has become familiar. First, the FDA acts through either an EUA or general approval, then the AICP, a committee of the CDC grants approval, followed by the 3rd step of full CDC approval. At that point – all expected in this latest EUA to…
Read MoreYour Coronavirus Update – Dec. 29, 2021
Photo: Stars & Stripes RHODE ISLAND & VICINITY Some hospitals are calling on the Governor to call in the National Guard – as RI hospitals now have the highest percentage of people in the hospital in the United States. An updated COVID-19 vaccine policy for City of Providence employees was announced, requiring all employees to…
Read MoreYour Coronavirus Update – Dec. 28, 2021
RHODE ISLAND & VICINITY The VA Medical Center is first hospital in RI to completely stop visitation due to omicron variant (exception for end-of-life). President Biden says the federal government will support the states and they should let him know if they need anything – but it is the states that will handle the COVID…
Read MoreNEW: CDC recommends immunocompromised get additional vaccine 28 days after 2nd vaccine
COVID-19 Vaccines for Moderately to Severely Immunocompromised People What You Need to Know People with moderately to severely compromised immune systems are especially vulnerable to COVID-19, and may not build the same level of immunity to 2-dose vaccine series compared to people who are not immunocompromised. CDC recommends that people with moderately to severely compromised…
Read MoreBREAKING: FDA approves Pfizer boosters for 65+ and high risk. Once CDC confirms, could start immediately.
The U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in: individuals 65 years of age and older; individuals 18 through 64 years of age at…
Read MoreNEW: Single-shot Johnson & Johnson vaccine goes from 79% to 94% efficacy with booster
Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. Additional data show a booster increases protection 94 percent protection in the U.S. with booster given at two monthsFour-fold increase in antibodies when given at two months 12-fold increase in antibodies when booster…
Read More